Universal Vision Biotechnology Co., Ltd. Stock
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
247.5 TWD | +0.41% | -2.94% | -10.65% |
Sales 2024 * | 4.36B 134M | Sales 2025 * | 5.07B 156M | Capitalization | 20.97B 646M |
---|---|---|---|---|---|
Net income 2024 * | 1.15B 35.55M | Net income 2025 * | - | EV / Sales 2024 * | 4.31 x |
Net cash position 2024 * | 2.18B 67.04M | Net cash position 2025 * | 2.51B 77.34M | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
-
| Employees | 401 |
Yield 2024 * |
2.93% | Yield 2025 * |
3.84% | Free-Float | 52.5% |
1 day | +0.41% | ||
1 week | -2.94% | ||
1 month | -3.32% | ||
3 months | -17.77% | ||
6 months | -14.36% | ||
Current year | -10.65% |
Managers | Title | Age | Since |
---|---|---|---|
Cheng Hung Lu
CEO | Chief Executive Officer | - | 10-01-31 |
Qiu Ju Hou
DFI | Director of Finance/CFO | - | 16-03-31 |
Pi Jung Lin
PSD | President | - | 03-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pi Jung Lin
PSD | President | - | 03-06-01 |
Shu Fang Ou
CHM | Chairman | - | 12-06-27 |
Min Chih Hsiao
BRD | Director/Board Member | 64 | 12-06-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.61% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 247.5 | +0.41% | 420,633 |
24-05-30 | 246.5 | -2.76% | 673,451 |
24-05-29 | 253.5 | -0.59% | 344,873 |
24-05-28 | 255 | -0.58% | 155,992 |
24-05-27 | 256.5 | +0.59% | 137,101 |
End-of-day quote Taipei Exchange, May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.65% | 645M | |
+13.05% | 101B | |
+22.39% | 43.96B | |
-20.50% | 2.22B | |
+25.60% | 2.11B | |
+19.17% | 1.13B | |
-38.32% | 716M | |
-44.53% | 632M | |
+57.22% | 606M | |
+15.96% | 463M |
- Stock Market
- Equities
- 3218 Stock